As the unsatisfactory performance posted by this season’s flu vaccines draws conversation around better prophylactic options, Novavax hopes to show that its new candidate could become one for older adults, who usually suffer the most from influenza.Original Article
Novavax’s flu vaccine for older adults shows early promise against Sanofi’s Fluzone
